Drug formulation is the process of combining an active drug with other ingredients to create a final product that’s safe, stable, and effective when it enters your body. It’s the reason the same painkiller can come as a tablet, a liquid, a patch, or an injection. The active ingredient might be identical, but the formulation determines how quickly it works, how long it lasts, where it goes in your body, and whether it remains potent on the pharmacy shelf for months or years.
The Building Blocks of a Formulation
Every pharmaceutical product has two categories of ingredients: the active pharmaceutical ingredient (the drug itself) and the excipients (everything else). The active ingredient is what treats your condition. Excipients are the supporting cast, and they do far more than fill space in a pill.
In a typical tablet, several types of excipients work together:
- Diluents provide bulk so that a tiny dose of a potent drug can be formed into a tablet large enough to handle.
- Binders hold the tablet together, giving it mechanical strength so it doesn’t crumble in the bottle.
- Disintegrants do the opposite once the tablet reaches your gut, helping it break apart so the drug can dissolve and be absorbed.
- Glidants and lubricants keep powders flowing smoothly through manufacturing equipment. Some, like starch and talc, serve both roles.
Choosing the wrong excipient can slow absorption, degrade the drug, or cause an unwanted interaction. The formulation process accounts for the drug’s particle size, crystal structure, acidity, and solubility before any of these ingredients are combined.
Why the Same Drug Comes in Different Forms
The FDA recognizes dozens of dosage forms: tablets, capsules, gels, solutions, suspensions, patches, suppositories, inhalers, chewable bars, soluble films, and more. Each exists because different situations call for different delivery strategies.
Oral forms like tablets and capsules are the most common because they’re convenient and stable. But some drugs are destroyed by stomach acid or absorbed too poorly through the gut wall. In those cases, formulators may turn to injectable solutions, inhalers that deliver the drug directly to the lungs, or patches that push it slowly through the skin. The choice of dosage form is never arbitrary. It’s dictated by the drug’s chemistry and the clinical goal.
How Formulation Affects What Your Body Absorbs
Two versions of the same drug can behave very differently in your bloodstream depending on how they’re formulated. This concept, called bioavailability, measures how much of the drug actually reaches your system and how fast.
Many promising drugs are hydrophobic, meaning they don’t dissolve well in water. Since your digestive tract is a watery environment, these drugs dissolve slowly and get absorbed poorly from a standard tablet. Lipid-based formulations solve this by pre-dissolving the drug in oils or fats. When you swallow a lipid formulation, it skips the slow dissolution step entirely and forms tiny droplets in your intestine, dramatically increasing the surface area available for absorption.
These fat-based systems can also protect a drug from being broken down by digestive enzymes and can promote absorption through the lymphatic system, which bypasses the liver’s first-pass metabolism. That matters because the liver filters out a significant portion of many oral drugs before they ever reach the rest of the body. Certain added compounds can even increase the permeability of intestinal cell membranes, letting more drug pass through.
Immediate, Delayed, and Extended Release
One of the most important decisions in formulation is how quickly the drug should be released once you take it.
Immediate-release formulations are designed to dissolve without any intentional delay. A typical immediate-release tablet disintegrates and releases 70% to 80% of its drug within one to four hours of swallowing. In lab testing, at least 85% of the drug is expected to dissolve within 60 minutes.
Delayed-release formulations hold back the drug until a specific trigger occurs. An enteric coating, for example, resists the acidic environment of the stomach and only dissolves once the tablet reaches the more alkaline small intestine. This protects drugs that would be destroyed by stomach acid, or protects the stomach lining from drugs that would irritate it.
Extended-release (also called sustained-release or controlled-release) formulations meter out the drug gradually over many hours. At steady state, the rate of drug entering the bloodstream roughly matches the rate at which the body eliminates it, keeping levels consistent. This reduces the peaks and valleys that come with taking an immediate-release pill every few hours, which can mean fewer side effects and less frequent dosing. Extended-release systems have been around for about 70 years and use various technologies: water-absorbing matrix systems, reservoir membranes, and osmotic pumps that push drug out through a tiny laser-drilled hole.
Topical and Transdermal Delivery
Getting a drug through the skin is a formulation challenge because the outermost layer of skin, the stratum corneum, is designed to keep foreign substances out. Formulators use several strategies to overcome this barrier.
Chemical penetration enhancers increase the skin’s permeability, a practice with ancient roots. Egyptian perfumers added essential oils to ointments for the same purpose thousands of years ago. Modern approaches include ionic liquids, which are liquid salts that can convert a drug into a form with higher solubility and better skin penetration. Deep eutectic solvents work by slipping between skin cells and creating small, temporary openings in cell membranes. Liquid crystals have a lipid structure similar to the skin itself, giving them strong adhesive properties that help hold a drug at the application site.
Transdermal patches take this further by providing a controlled, steady dose over hours or days. The formulation inside the patch must balance the drug’s release rate with the skin’s absorption capacity to maintain a therapeutic level without irritation.
Injectable Formulations and Sterility
Drugs delivered by injection bypass the digestive system entirely, which makes them useful for drugs that can’t survive the gut or need to act immediately. But injectable formulations carry stricter requirements than oral ones. They must be sterile, and their pH and salt concentration need to be compatible with blood and tissue. Even the rubber or plastic closure on the vial must be chosen carefully based on the drug’s chemistry, its preservatives, and its pH, since the wrong material can leach contaminants or react with the solution inside.
The Development Process
Formulation development starts well before a drug reaches a pharmacy. In the preformulation stage, scientists characterize the drug’s physical and chemical personality: its melting point, how acidic or basic it is, how well it dissolves in water, how it partitions between oil and water (a measure of how easily it crosses biological membranes), and whether it’s stable in solution. These data points guide every subsequent decision about dosage form, excipient selection, and manufacturing method.
Often, early drug discovery teams focus so heavily on finding a molecule that works in the lab that its physical properties take a back seat. Formulation scientists then inherit a compound that may be poorly soluble, chemically fragile, or difficult to manufacture into a stable product. Their job is to engineer around those limitations.
Once a prototype formulation exists, it undergoes rigorous stability testing under international guidelines. Products are stored at controlled temperatures and humidity levels to simulate real-world conditions across different climate zones, from temperate regions to hot and humid tropics. These tests determine the drug’s shelf life and storage requirements.
Nano-Scale Formulation
Nanoparticles, particles measured in billionths of a meter, represent one of the most active areas in formulation science. At this scale, drug carriers can improve how a drug distributes through the body and accumulates at a disease site while reducing exposure to healthy tissue. This is particularly valuable in cancer treatment, where conventional drugs damage healthy cells alongside tumor cells.
Nanoparticle systems protect drugs from biological degradation and can be engineered with surface molecules that recognize and bind to specific cell types. Some systems use magnetic fields to guide drug-loaded particles to a target location. The global drug delivery systems market, which includes these advanced formulations, was valued at roughly $44 billion in 2025 and is projected to reach nearly $63 billion by the mid-2030s, reflecting the scale of investment in better ways to get drugs where they need to go.